🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Quadrivalent influenza virus subunit vaccine

Found 17 matching trials

H3N2 M2SR in Pediatric Population

PHASE1

This is a Phase I double-blind, randomized, placebo-controlled study in 50 ...

Status

Completed

Location

Saint Louis University - Center for Vaccine Development

Start Date

2018-08-15

Trial ID

NCT03553940

Treatments Being Tested

Influenza Virus Monovalent A/H3N2/Bris 10 M2SR Live Vaccine Placebo Quadrivalent MDCK Inactivated Influenza Vaccine

Safety, Reactogenicity, Immunogenicity, Efficacy of Influenza Vaccines Grippol® Quadri and Grippol® Plus in Volunteers

PHASE2

The aim of the study to assess the safety, reactogenicity, immunogenicity, ...

Status

Completed

Location

Federal State Budgetary Educational Institution of Higher Education "First St. Petersburg State Medical University named after academician I.P. Pavlova "of the Ministry of Health of the Russian Federation.

Start Date

2016-11

Trial ID

NCT03849560

Treatments Being Tested

Grippol® Quadri Grippol® Plus, trivalent (Yamagata lineage)Grippol® Plus, trivalent (Victoria lineage)

Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age

PHASE2

This Phase 2, randomized, observer-blind, dose-confirmation clinical study ...

Status

Completed

Location

AMR Tempe

Start Date

2022-08-25

Trial ID

NCT05501561

Treatments Being Tested

Experimental: IIV-A Investigational IIV-A administered as a single dose intramuscularly on Day 1 Experimental: aIIV-B Investigational aIIV-B administered as a single dose intramuscularly on Day 1 Experimental: aIIV-C Investigational aIIV-C administered as a single dose intramuscularly on Day 1 Active Comparator: Licensed IIV IIV administered as a single dose intramuscularly on Day 1

Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older

PHASE3

Evaluate safety and immunogenicity of three influenza vaccines in adults 18...

Status

Completed

Location

Multiple Locations

Start Date

2013-11

Trial ID

NCT01992094

Treatments Being Tested

QIVc TIV1c TIV2c

Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to <18 Years of Age

PHASE3

This Phase 3/4, randomized, observer-blind, multi-center study, stratified ...

Status

Completed

Location

302 AusTrials Pty Ltd

Start Date

2017-05-25

Trial ID

NCT03165617

Treatments Being Tested

QIVc Non-influenza Comparator Vaccine

Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine (QIV) in Children Previously Vaccinated in Trial V118_05

PHASE3

Safety, Immunogenicity of an Adjuvanted Quadrivalent Subunit Influenza Viru...

Status

Completed

Location

Multiple Locations

Start Date

2014-10

Trial ID

NCT02255409

Treatments Being Tested

Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)non-adjuvanted Quadrivalent Influenza Vaccine (QIV)

Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults

PHASE2

This Phase 2, randomized, observer-blind, antigen and adjuvant dose-ranging...

Status

Completed

Location

03607 - PCRN_Paratus Clinical Research

Start Date

2021-04-13

Trial ID

NCT04782323

Treatments Being Tested

aQII-1 aQII-3 Investigational aQII-6 Investigational aQII-7 Investigational aQII-9 Investigational aQII-10 Investigational aQII-11 Investigational Licensed QII Active Comparator

Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.

PHASE3

Safety, Immunogenicity and Efficacy of an Adjuvanted Quadrivalent Subunit I...

Status

Completed

Location

222, Novartis Investigational Site

Start Date

2013-11

Trial ID

NCT01964989

Treatments Being Tested

Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV)

Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old

PHASE3

Evaluate safety and immunogenicity of three influenza vaccines in children ...

Status

Completed

Location

Multiple Locations

Start Date

2013-11

Trial ID

NCT01992107

Treatments Being Tested

QIVc TIV1c TIV2c

Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults

PHASE2

This Phase 2, randomized, observer-blind, active controlled clinical study ...

Status

Completed

Location

4022 - Coastal Clinical Research, an AMR company

Start Date

2020-10-08

Trial ID

NCT04576702

Treatments Being Tested

Investigational aIIV4c IIV4c aIIV4 RIV4

Previous Next